RaQualia Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2021
RaQualia Pharma Inc. announced consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported net sales were ¥655 million against ¥123 million a year ago. Operating profit was ¥149 million against operating loss of ¥273 million a year ago. Profit was ¥188 million against loss of ¥328 million a year ago. Basic earnings per share was ¥9.00 against basic loss per share of ¥15.66 a year ago.